Publish your immunology research

Our portfolio of immunology-focused journals delivers innovative, peer-reviewed research to a global audience of clinicians, researchers, academics, and other key opinion leaders in the healthcare and pharmaceutical industry.

We work with all of the top 10 largest drug companies ranked by Forbes¹ and 86% of the top 50 global pharma companies ranked by Pharmaceutical Executive.²

The immunology portfolio covers a wide range of topics, including but not limited to: 

  • Anaphylaxis and allergy
  • Autoimmune diseases
  • Cancer immunology and immunotherapies
  • Congenital and acquired immunodeficiencies
  • Hematological diseases
  • Immune-mediated skin disorders
  • Immuno-endocrinology and diabetes
  • Infection and immunity
  • Neuroimmunology and inflammation
  • Organ-specific inflammatory diseases
  • Transplantation immunology
  • Vaccination for infectious and non-infectious diseases

Like you, we value high visibility and timely publication. To extend your research impact, publish open access and use our Accelerated Publication service, which fast-tracks your article from submission to online publication in as little as three weeks. Help your article reach non-specialist audiences by publishing a Plain Language Summary (PLS).

Interested in publishing with us?

Our editorial team is happy to speak with you about the best options for your paper.

Explore the immunology portfolio

Featured journals

OncoImmunology*

High-profile, open access research in fundamental, translational and clinical areas of tumor immunology.

2020 Impact Factor: 8.11‡

Expert Review of Vaccines†

Expert commentary on the development, application, and clinical effectiveness of new vaccines, with topics including vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines.

2020 Impact Factor: 5.217‡

mAbs*

A multi-disciplinary journal dedicated to the art and science of antibody research and development.

2020 Impact Factor: 5.857‡

Expert Review of Clinical Immunology†

A centralized resource of commentary and debate for the clinical immunology community to inform clinical and economic decision making in healthcare delivery.

2020 Impact Factor: 4.473‡

Find the right journal for your immunology research

Expert Review of Vaccines†
Impact Factor: 5.217‡  

Expert Review of Clinical Immunology†
Impact Factor: 4.473‡

Expert Opinion on Biological Therapy†
Impact Factor: 4.388‡

Expert Review of Respiratory Medicine†
Impact Factor: 3.772‡

Expert Review of Hematology†
Impact Factor: 2.929‡

Expert Opinion on Orphan Drugs†
Impact Factor: 0.694‡

*Fully open access journal.
†Offers Accelerated Publication.
‡Copyright: 2019 Journal Citation Reports®, Clarivate Analytics, 2020.
§Published by Dove Medical Press.

Why publish with Taylor & Francis?

Blue check icon
Quality

Research articles are assessed by independent peer reviewers for quality, validity, and relevance. Many journals in our medical portfolio are indexed in the Science Citation Index, Science Citation Index Expanded, Scopus, and MEDLINE.

Blue scale icon
Ethics

Taylor & Francis upholds the highest standards of ethical publishing. We comply with ICMJE, COPE, and GPP-3 guidelines.

Blue speaker icon
Reach

Taylor & Francis is a leading scholarly publisher. Amazon’s Alexa service ranks Taylor & Francis Online among the world’s most-visited academic journals publishing platforms.

Blue information icon
Expertise

Contributors to our medical journals benefit from direct and prompt communication with in-house editorial specialists.

Blue silhouette icon
Industry peers

Taylor & Francis publishes research from top pharmaceutical companies like GlaxoSmithKline, Sanofi Pasteur, Merck & Co., and Roche.

Blue gears icon
Additional services for corporate researchers

Our Commercial Services team can tailor ad placements, reprint packages, and research access options to fit your organization's needs.

Want to learn more?

Complete the online enquiry form on this page for a direct response from a member of our editorial team.